Clinic-based Translational Research

Slides:



Advertisements
Similar presentations
Specimen Model Project: Requirements from Clinical Genomics Mukesh Sharma Washington University Medical School St. Louis October 2010 WG meeting.
Advertisements

Sub module 2 Use of standardized records and registers.
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
East Africa DATA East African IeDEA PI Meeting Zanzibar, Tanzania May 4, 2010 Beverly Musick Regional Data Manager.
HLA-B57 does not fully explain the ability of HIV controllers to clear HCV infection Alice K. Asher 1, RN, MS; Glenn-Milo Santos 1, MPH; Jennifer Evans,
Funding of Cohort Studies Diana Finzi, Ph.D. Chief, Pathogenesis and Basic Research Branch Division of AIDS National Institutes of Health Bethesda, Maryland,
Marian Kerbleski, RN UCSF AIDS Division San Francisco General Hospital.
University of Pittsburgh Department of Biomedical Informatics Healthcare institutions have established local clinical data research repositories to enable.
Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
University of California, San Francisco San Francisco General Hospital
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Highlights of MACS and WIHS Protocol and Cohorts Lisa Jacobson Stephen Gange May 25, 2005 Not for distribution or publication outside the Multicenter AIDS.
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
Changes in population-level HIV RNA distribution one year after implementation of key components of an HIV ‘test and treat’ strategy in rural Uganda Vivek.
TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with.
The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Challenges in monitoring ARV therapy A clinical and public health view of the issues involved Charlie Gilks SRM team, HIV department.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Retention in Care among HIV-infected Patients Receiving Antiretroviral Therapy in Africa: Estimation via a Sampling-based Approach Elvin Geng 1, David.
Implementing an Electronic Medical Record System in a Rural HIV Clinic in Uganda Nicholas Musinguzi 1, Elvin H. Geng 2, David R. Bangsberg 3, Nneka I.
Failure to Initiate ART, Loss to Follow-up and Mortality among HIV-infected Patients during the pre-ART period in Uganda Elvin H. Geng 1, Winnie Muyindike.
Provider initiated testing in Kenya Ruth Nduati Associate Prof Paediatrics University of Nairobi.
Clinic-based Translational Research Cohort/ Clinical Trial Immunology Core Lab (Sinclair) Basic Immunology Lab (McCune) Virology Core Lab (Liegler) Basic.
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
Retention in care and connection to care among HIV-infected patients receiving ART n Africa: Estimation via a sampling-based approach Elvin Geng 1, David.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Integrated Community HIV Testing Campaigns: Leveraging HIV infrastructure for non- communicable diseases July 23, 2012 Gabriel Chamie, Dalsone Kwarisiima,
Conclusions Materials and Methods Background Objectives HIV-1 RNA is the most significant determinant of cervical HIV-1 shedding. Shedding has also been.
Frameworks for Getting to Zero: San Francisco’s Getting to Zero Initiative H Scott, S Weber, D Van Gorder, J Sheehy, D Gonzalez, J Loduca, C Supanich,
CaTissue Suite 1.2 TPBT Face to Face Michelle Lee, MBA, Ph.D. Ian Fore, D. Phil. December, 2009.
CaTissue Suite 1.2 TPBT Face to Face Michelle Lee, MBA, Ph.D. Ian Fore, D. Phil. December, 2009.
The “rare patient” Julia del Amo ISCIII, Madrid, Spain.
National Immunization Conference March 2006 Integrating Immunization Registries with a Disease Surveillance and Management System Michael L. Popovich
1 Predictors of Immunological Failure Among Adult Patients Receiving ART at an urban, HIV Clinic in Uganda Dr. Muhumuza Simon (M.D, MPH) Mulago-Mbarara.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
11/21/2014 CFAR Mentoring Core Facilities at UCSF and Beyond Teri Liegler, PhD Director ARI-UCSF Laboratory of Clinical Virology CFAR Virology Core Laboratory.
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
Prolonged HIV-1 Remission and Viral Rebound in an Individual Treated During Hyperacute Infection Timothy Henrich, Hiroyu Hatano, Alison Hill, Oliver Bacon,
New WHO Guidelines on Person centred monitoring
Tissue Collection & Banking Facility
Organizational Structure and Controls
Differentiated Monitoring & Evaluation
Emory University School of Medicine Department of Medicine
Title Ugandan Non-Communicable Diseases and Aging Cohort Study (NCT )
Organizational Structure and Controls
UCSF Core Facilities Enterprise
CDA Document ‘Executive’ Summary Section
16 Personal Health Records.
Clinic-based Translational Research
Specimen Processing and Analytical Nexus
Matthew H. Liang, MD Malcolm P. Rogers, MD Ira R. Katz, MD, PhD
Syndemics Predict Bio-Behavioral HIV Sexual Transmission Risk Behavior Longitudinally in US HIV Clinics Satyanand Satyanarayana, Steven A. Safren, Brooke.
Nittaya Phanuphak, MD, PhD 
Digital Health-eMpower in Vihaan
Core Facilities at UCSF and Beyond
OVC_HIVSTAT HIV Risk Assessment Prototype.
Farah Kidwai-Khan, Janet Tate, Cynthia Brandt, Amy Justice
Illustrative Cluster Detection and Response Strategy
Lesson 3: The HCV Care Continuum
Stakeholder engagement and research utilization: Insights from Namibia
REACHnet: Research Action for Health Network
Presentation transcript:

Clinic-based Translational Research Cohort/ Clinical Trial Immunology Core Lab (Milush) Basic Immunology Lab (McCune/Hunt) Virology Core Lab (Liegler) Basic Virology Lab (Wong/Henrich) Cardiology (Hsue) GI (Somsouk) LN FNA (Vohra) Neurology (Price)

Productivity Mostly Attributable to Data and Biological Specimens from the Cohorts SCOPE UARTO ISS Clinic No. of subjects 1938 750 22,087 Location San Francisco Mbarara, Uganda Cohort type Dynamic Fixed Entry Criteria Demand-driven collection of both prototypical & rare clinical phenotypes Consecutive ART starters at a prototypical municipal ART clinic All patients at a prototypical municipal ART clinic Paper-based measurements Research-dedicated During course of clinical care Biologic specimens Serum, plasma, PBMCs, saliva -- Follow-up 4 months Clinically-driven Special procedures Gut & lymph node biopsies, apheresis Real time adherence monitoring Active tracking of drop outs The productivity of the Core is mostly attributable to the data and biological specimens that are derived from the supported cohorts.

Clinical Cohorts SCOPE: Chronically HIV-infected patients Enriched for “extreme phenotypes” (elite controllers, viremic non- progressors, immunologic non-responders, etc). Key Faculty: Steve Deeks, Jeff Martin, Peter Hunt OPTIONS: Recently/Acutely HIV-infected patients Boutique Cohorts: Transmission pairs, Highly exposed HIV- uninfected patients Key Faculty: Rick Hecht, Chris Pilcher WIHS: Multi-center cohort of HIV-infected women and risk-matched HIV-negative controls Key Faculty: Ruth Greenblatt, Phyllis Tien

Domestic Cohort Linkages Our cohorts not only provide data and specimens themselves to CFAR users but also are linked to larger networks and thus give CFAR users broader opportunities. Specifically, ….

International Cohort Linkages Central Africa ISS Clinic Cohort Internationally, there is similar nesting and linkage. UARTO

Other Research Networks ACTG (AIDS Clinical Trials Group) Diane Havlir (TB TSG Vice Chair) Peter Hunt (Inflammation/End-organ Disease Chair) CNICS (CFAR Network of Integrated Clinical Systems) Linked electronic medical records across multiple HIV clinics Specimens available to link biomarkers to rare clinical outcomes Key Faculty: Elvin Geng, Steve Deeks, Peter Hunt, Jeff Martin

Core Metrics: 2012-2013 * including submitted Item Number Projects Total 144 International 33 Users 205 UCSF CFAR 69 Other CFARs 57 Non-CFAR 79 Early Stage Investigators 38 Publications* 60 Conference Presentations 58 * including submitted And, in brief, some of the important metrics of the Core.

48 separate specimen shipments to investigators Real time inventory Rapid distribution Specimen Type No. Unique Timepoints Plasma 2080 Serum 450 Viable PBMC 947 Non-viable PBMC 768 2012: 48 separate specimen shipments to investigators

Innovation: Linkage to CNICS Specimen Repository March 25, 1987 to present 8 contributing sites CWRU - Fenway JHU - UAB UCSD - UCSF UNC - UW 661,880 aliquots - from 77,819 unique timepoints -- from 11,414 HIV-infected patients 9